
Immuneering Corporation - Class A Common Stock
Action · US45254E1073 · IMRX (XNAS)
2,29 USD
06.06.2025 23:54
Cours actuels de Immuneering Corporation - Class A Common Stock
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NASDAQ |
IMRX
|
USD
|
06.06.2025 23:54
|
2,29 USD
| 2,05 USD
+11,65 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | 37,06 % | 100,66 % | 50,59 % | 4,52 % | 67,07 % | -86,99 % |
Profil de l'entreprise pour Immuneering Corporation - Class A Common Stock Action
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.
Données de l'entreprise
Nom Immuneering Corporation - Class A Common Stock
Société Immuneering Corporation
Symbole IMRX
Site web
https://immuneering.com
Marché d'origine
NASDAQ

ISIN US45254E1073
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Capitalisation boursière 46 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 245 Main Street, 02142 Cambridge
Date d'introduction en bourse 2021-07-30
Symboles boursiers
Nom | Symbole |
---|---|
NASDAQ | IMRX |
Autres actions
Les investisseurs qui détiennent Immuneering Corporation - Class A Common Stock ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.